Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting

OBJECTIVE: Our objective was to evaluate the long-term cost-effectiveness of once-weekly semaglutide 1 mg versus once-daily canagliflozin 300 mg in patients with type 2 diabetes mellitus (T2DM) uncontrolled with metformin from the healthcare payer and societal perspectives in Canada. METHODS: Head-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stafford, Sara, Bech, Peter G., Fridhammar, Adam, Miresashvili, Nino, Nilsson, Andreas, Willis, Michael, Liu, Aiden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206917/
https://www.ncbi.nlm.nih.gov/pubmed/35344191
http://dx.doi.org/10.1007/s40258-022-00726-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206917/
https://www.ncbi.nlm.nih.gov/pubmed/35344191
http://dx.doi.org/10.1007/s40258-022-00726-z

Ejemplares similares